Invention Grant
- Patent Title: Hepatitis C virus inhibitors
- Patent Title (中): 丙型肝炎病毒抑制剂
-
Application No.: US13919027Application Date: 2013-06-17
-
Publication No.: US09018390B2Publication Date: 2015-04-28
- Inventor: Carol Bachand , Makonen Belema , Daniel H. Deon , Andrew C. Good , Jason Goodrich , Clint A. James , Rico Lavoie , Omar D. Lopez , Alain Martel , Nicholas A. Meanwell , Van N. Nguyen , Jeffrey Lee Romine , Edward H. Ruediger , Lawrence B. Snyder , Denis R. St. Laurent , Fukang Yang , David R. Langley , Lawrence G. Hamann
- Applicant: Bristol-Myers Squibb Company
- Applicant Address: US NJ Princeton
- Assignee: Bristol-Myers Squibb Company
- Current Assignee: Bristol-Myers Squibb Company
- Current Assignee Address: US NJ Princeton
- Agent Pamela A. Mingo
- Main IPC: C07D233/00
- IPC: C07D233/00 ; C07D233/02 ; A01N43/50 ; A61K31/415 ; C07D403/14 ; A61K31/4178 ; A61K31/4545 ; A61K31/5377 ; A61K31/695 ; A61K45/06 ; C07D401/14 ; C07F7/10
Abstract:
The present disclosure relates to compounds, compositions and methods for the treatment of hepatitis C virus (HCV) infection. Also disclosed are pharmaceutical compositions containing such compounds and methods for using these compounds in the treatment of HCV infection.
Public/Granted literature
- US20130280211A1 Hepatitis C Virus Inhibitors Public/Granted day:2013-10-24
Information query
